WATCH TV LIVE

NEWSMAX TV HEALTH MONEY WORLD
Tags: clinical trial | vaccine | vector institute | ria

Russia to Complete Early-Stage Trials on 2nd COVID-19 Vaccine on Sept. 30

russian pharmaceutical factory with people walking inside the building
A view of the pharmaceutical factory Binnofarm in the town of Zelenograd outside Moscow on August 12, 2020, where Russia is starting to produce the anti-coronavirus vaccine. (Alexander Nemenov/Getty Images)

Monday, 07 September 2020 06:57 AM EDT

Russia will complete early-stage trials on a second potential COVID-19 vaccine produced by the Vector Institute on Sept. 30, the RIA news agency cited Russia's consumer health safety watchdog as saying on Monday.

© 2026 Thomson/Reuters. All rights reserved.


Click Here to comment on this article
Share
GlobalTalk
Russia will complete early-stage trials on a second potential COVID-19 vaccine produced by the Vector Institute on Sept. 30, the RIA news agency cited Russia's consumer health safety...
clinical trial, vaccine, vector institute, ria
33
2020-57-07
Monday, 07 September 2020 06:57 AM
Newsmax Media, Inc.

Sign up for Newsmax’s Daily Newsletter

Receive breaking news and original analysis - sent right to your inbox.

(Optional for Local News)
Privacy: We never share your email address.
Join the Newsmax Community
Read and Post Comments
Please review Community Guidelines before posting a comment.
 
 
TOP

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved
NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved